trial
as of 2026-07-01Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
NCTId NCT02304432
at a glance
Early Phase 1 · Completed
Enrollment 2 (actual)
Sponsored by Mclean Hospital
Primary completion 2016-09-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Early Phase 1
Status
Completed
Enrollment
2 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2015-09-27
Primary completion
2016-09-30
Eligibility
ALL · 34 Years · 62 Years
Interventions & indications
Sponsors
Mclean HospitalLead Sponsor
University of MinnesotaCollaborator
Investigators
1
Deborah L. Levy, Ph.D.Principal Investigator
Sites
0 total
Facts & assertions
4 sourced
Enrollment
2
Phase
EARLY_PHASE1
Primary Completion Date
2016-09-30
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
collaborator
company
indication
investigator
person